NCT03298204

Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01

A Multicenter Analysis of Definitive (Chemo)Radiotherapy With or Without Chemotherapy for Patients With Esophageal Cancer - 3JECROG-R01

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 2,762 (actual)
• Sponsor: Chinese Academy of Medical Sciences · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The aim of this observational study is to retrospectively collect survival data for 3000 primary esophageal cancer patients from multicenter between January 2000 to present. Based on a Cox model, we want to develope a nomogram that predicts local recurrence, distant metastases, and survival for patients treated with radiotherapy or chemoradiotherapy with or without chemotherapy.

Conditions

• Esophagus Cancer
• Chemoradiation
• Chemotherapy Effect
• Radiotherapy Side Effect

Timeline

• Start date: 2017-06-01
• Primary completion: 2017-09-30
• Completion: 2018-02-28
• First posted: 2017-10-02
• Last updated: 2019-01-02

Locations

1 site across 1 country: China